| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Inspire Medical Systems (NYSE:INSP) raises FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.90-$1.00 vs $0.45 analyst estimate. ...
																	Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of...
																	
																	
																	
																	
																	Jefferies analyst Michael Sarcone downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Hold and lowers the price targe...
																	Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price ta...
																	Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...